Exploring the Role of MicroRNAs in Bladder Cancer Prognosis and Treatment Response
Journal of Health, Wellness and Community Research · 04.07.2026 · 1-13
DOI: 10.61919/37p0mp65 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 04.07.2026. Verfasst von Umar Farooq und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bladder cancer is a common urological malignancy associated with recurrence, progression, and repeated invasive surveillance. MicroRNAs have emerged as potential molecular biomarkers because they regulate tumor growth, invasion, and treatment-related pathways.
Objective
To compare selected microRNA expression between bladder cancer patients and controls and to examine their association with clinicopathological aggressiveness, treatment response, and diagnostic discrimination.
Methods
This hospital-based analytical molecular genetics study included 120 participants, comprising 90 histologically confirmed bladder cancer patients and 30 controls. Selected microRNAs, including miR-21, miR-155, miR-145, miR-99a, and miR-125b, were analyzed using quantitative real-time polymerase chain reaction, and relative expression was calculated using the 2^−ΔΔCT method. Expression patterns were compared between groups and examined according to tumor grade, disease stage, and treatment-response records. Results: miR-21 and miR-155 were increased in bladder cancer patients, while miR-145, miR-99a, and miR-125b were reduced. miR-21 showed the strongest increase in cancer patients compared with controls, while miR-145 showed the most marked reduction. Higher miR-21 and miR-155 and lower miR-145 were associated with high-grade tumors, muscle-invasive disease, and poor response or recurrence. miR-21 showed the highest individual diagnostic performance, while the combined miR-21 and miR-145 panel showed the best discrimination.
Conclusion
Selected microRNAs showed clinically relevant expression differences in bladder cancer and may support exploratory diagnosis and risk stratification. Larger prospective validation studies are required before clinical application
Zitieren
APA
Farooq, U., Masood, A., Khan, I. Z., Ghani, G., Manzoor, A., & Ali, A. (2026). Exploring the Role of MicroRNAs in Bladder Cancer Prognosis and Treatment Response. Journal of Health, Wellness and Community Research, 1-13. https://doi.org/10.61919/37p0mp65
Vancouver
Farooq U, Masood A, Khan IZ, Ghani G, Manzoor A, Ali A. Exploring the Role of MicroRNAs in Bladder Cancer Prognosis and Treatment Response. Journal of Health, Wellness and Community Research. 2026:1-13. doi:10.61919/37p0mp65
BibTeX
@article{Farooq2026,
author = {Farooq, Umar and Masood, Asher and Khan, Imran Zahoor and Ghani, Gul and Manzoor, Ayesha and Ali, Asghar},
title = {Exploring the Role of MicroRNAs in Bladder Cancer Prognosis and Treatment Response},
journal = {Journal of Health, Wellness and Community Research},
year = {2026},
pages = {1--13},
doi = {10.61919/37p0mp65}
}
EUVIMED